Newsroom

Industry News

16 Nov

Tβ4’s Role in Treatment of Eye Diseases Showcased at 5th International Thymosin Symposium

ROCKVILLE, Md., Nov. 16, 2017 /PRNewswire/ — RegeneRx Biopharmaceuticals, Inc. (RGRX) (“the Company” or “RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that Thymosin beta 4 (Tβ4), the active ingredient in RGN-259, a preservative-free ophthalmic eye drop, was the subject of a Keynote Address at the...

Read more

16 Nov

Zomedica Pharmaceuticals Corp. Expects Trading of its Common Shares on the NYSE American to Commence on November 21, 2017

ANN ARBOR, Mich., Nov. 16, 2017 (GLOBE NEWSWIRE) — Zomedica Pharmaceuticals Corp. (ZOM.V) (NYSE American:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, today announced that the NYSE American has advised that trading of the Company’s common shares under the symbol “ZOM” will commence on November 21, 2017,...

Read more

15 Nov

OncoCyte Reports Third Quarter 2017 Financial Results

ALAMEDA, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) — OncoCyte Corporation (NYSE American:OCX), a developer of novel, non-invasive tests for the early detection of cancer, today reported financial results for the quarter ended September 30, 2017, and provided an update on the Clinical Validation Study of DetermaVu™, the Company’s liquid biopsy lung...

Read more

15 Nov

The Crypto Company Announces Third Quarter 2017 Financial Results

LOS ANGELES, CA / ACCESSWIRE / November 15, 2017 / The Crypto Company (OTC PINK: CRCW), one of the first publicly traded technology companies in the digital currencies and blockchain sector, today announced financial results for the third quarter of 2017, ended September 30, 2017. “This has been an exciting...

Read more

14 Nov

ProBility Media Completes $1.4 Million Promissory Note and Warrant Private Placement

HOUSTON, TX–(Marketwired – Nov 14, 2017) – ProBility Media Corp. ( OTCQB : PBYA ), an EdTech company building the first full-service training and career advancement brand for the skilled trades, today announced the completion of a private placement of original issue discount amortizable promissory notes in the aggregate principal amount of $3,383,325....

Read more

14 Nov

Ascent Solar Announces Further Improvement in Third Quarter 2017 Financial Results

THORNTON, CO–(Marketwired – Nov 14, 2017) – Ascent Solar Technologies, Inc. (OTCBB : ASTI ), a developer and manufacturer of state-of-the-art, lightweight, and flexible thin-film photovoltaic (PV) solutions, reported results for the quarter ended September 30, 2017. Q3 2017 Financial Results: The Company posted net revenue of $242K for Q3 2017, a...

Read more

14 Nov

Mateon Provides Corporate Update and Reports Third Quarter 2017 Financial Results

SOUTH SAN FRANCISCO, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) — Mateon Therapeutics, Inc. (MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications, today provided a corporate update and reported financial results for the three months ended September 30, 2017. Recent Corporate Highlights Announced phase...

Read more

13 Nov

CymaBay Therapeutics to Present at Three Investor Conferences

NEWARK, Calif., Nov. 13, 2017 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that management will provide a corporate overview at the 29th Annual Piper Jaffray Healthcare Conference, the Evercore/ISI 2017...

Read more

Page 10 of 276« First...89101112...203040...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address